A novel thymosin peptide stimulates lnterleukin-6 release from rat C6 glioma cells in vitro

NeuroImmunoModulation

Volumn 4, Issue 3, 1997, Pages 163-170

  Tijerina, Monica ^a   Gorospe, William C ^b   Bowman, Kay Lynn ^a   Badamchian, Mahnaz ^c   Goldstein, Allan L ^c   Spangelo, Bryan L ^a  

^a UNIVERSITY OF NEVADA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c GEORGE WASHINGTON UNIVERSITY   (United States)

Author keywords

C6 glioma cells; Cytokines; Interleukin 6; Thymosin; Thymus

Indexed keywords

INTERLEUKIN 6; PHORBOL 13 ACETATE 12 MYRISTATE; THYMOSIN ALPHA1; THYMOSIN BETA4; THYMOSIN FRACTION 5;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; GLIOMA CELL; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; RAT; THYMUS;

ANIMALS; CATTLE; CELLS, CULTURED; GLIOMA; INTERLEUKIN-6; PEPTIDES; PROTEIN KINASE C; RATS; THYMOSIN;

EID: 13144276316     PISSN: 10217401     EISSN: 14230216     Source Type: Journal    
DOI: 10.1159/000097334     Document Type: Article

References (31)

1. Spangelo BL, Hall NR, Goldstein AL: Biology and chemistry of thymosin peptides: Modulators of immunity and neuroendocrine circuits, Ann NY Acad Sci 1987;496:196-204.
2. Spangelo BL: The thymic-cndocrinc connection, J Endocrinol 1995;147:5-10.
3. Hadden EM, Malee P, Sosa M, Hadden JW: Mixed interleukins and thymosin fraction V synergist ically induce T lymphocyte development in hydrocortisone-treated aged mice, Int J Immunopharmacol 1992;14:345-352.
4. Ikemoto S, Kamizuru M, Hayahara N, Okamoto S, Wada S, Kishimoto T, Maekawa M: Thymus lymphocytes in uraemic rats and the effect of thymosin fraction 5 in vivo, Clin Exp Immunol 1992:87:220-223.
5. t potentiates the anti-tumor activity of intcrlcukin-2 with cyclophosphamide in the treatment of the Lewis lung carcinoma in mice, Int J Cancer 1992;50:493-499.
6. Favalli G, Mastino A, Jezzi T, Creili S, Goldstein AL, Garaci E: Synergistic effect of thymosin αβ and α/β-interferon on NK activity in tumor bearing mice, Int J Immunopharmacol 1989:11:443-450.
7. Kouttab NM, Goldstein AL, Lu M, Lu L, Campbell B, Maizel AL: Production of human B and T cell growth factors is enhanced by thymic hormones, Immunopharmacology 1988;16:97-105.
8. Attia WY, Badamchian M, Goldstein AL, Spangelo BL: Thymosin stimulates interlcukin-6 production from rat spleen cells in vitro, Immunopharmacology 1993;26:171-179.
9. McGillis JP, Hall NR, Vahouny GV, Goldstein AL: Thymosin fraction 5 causes increased serum corticosterone in rodents in vivo, J Immunol 1985;134:3952-3955.
10. Healy DL, Hodgen GD, Schulte HM, Chrousos GP, Loriaux DL, Hall NR, Goldstein AL: The thymus-adrcnal connection: Thymosin has corticotropin-releasing activity in primates, Science 1983;222:1353-1355.
11. Spinedi E, Iladid R, Daneva T, Gaillard RC: Cytokines stimulate the CRH but not the vasopressin neuronal system: Evidence for a median eminence site of intcrlcukin-6 action, Ncurocndocrinology 1992;56:46-53.
12. Milenkovic L, McCann SM: Effects of thymosin alpha-1 on pituitary hormone release, Ncu-roendocrinology 1992:55:14-19.
13. Milenkovic L, Lyson K, Aguila MC, McCann SM: Effect of thymosin ai on hypothalamic hormone release, Ncurocndocrinology 1992; 56:674-679.
14. Spangelo BL, Judd AM, Ross PC, Login IS, Jarvis WD, Badamchian M, Goldstein AL, MacLeod RM: Thymosin fraction 5 stimulates prolactin and growth hormone release from anterior pituitary’ cells in vitro, Endocrinology 1987; 121:2035-2043.
15. Badamchian M, Spangelo BL, Damavandy T, MacLeod RM, Goldstein AL: Complete amino acid sequence analysis of a peptide isolated from the thymus that enhances release of growth hormone and prolactin, Endocrinology 1991;128:1580-1588.
16. Goya RG, Castro MG, Hannah MJ, Sosa YE, Lowry PJ: Thymosin peptides stimulate corticotropin release by a calcium-dcpcndcnt mechanism, Ncurocndocrinology 1993;57:230-235.
17. Bianchi E, Pierpaoli W, Sorkin E: Cytological changes in the mouse anterior pituitary after neonatal thymectomy; A light and electron microscopical study, J Endocrinol 1971:51:1-6.
18. Pierpaoli W, Sorkin E: Relationship between thymus and hypophysis, Nature 1967;215: 834-837.
19. Gorospe WC, Fong YY, Spangelo BL: Thymosin fraction 5 modulates steroidogenesis and interleukin-6 release by rat ovarian granulosa cells in vitro, Endocr J 1993;1:35-39.
20. Zhang Y, Saito H, Nishiyama N: Thymectomy-induced deterioration of learning and memory in mice, Brain Res 1994;658:127-134.
21. Goya RG, Takahashi S, Quigley KL, Sosa YE, Goldstein AL, Meites J: Immune-neuroendocrine interactions during aging: Age-dependent thyrotropin-inhibiting activity of thymosin peptides, Mech Ageing Dev 1987;41:219-227.
22. Gatti S, Bartfai T: Induction of tumor necrosis factor-a niRNA in the brain after peripheral endotoxin treatment: Comparison with inter-leukin-l family and interleukin-6, Brain Res 1993;624:291-294.
23. Spangelo BL, Judd AM, Call GB, Zumwall J, Gorospe WC: Role of the cytokines in the hypothalamic-pituilary-adrcnal and gonadal axes, Ncuroimmunomodulation 1995:2:299-312.
24. Badamchian M, Wang S-S, Spangelo BL, Da-mavandy T, Goldstein AL: Chemical and biological characterization of MB-35: A thymic-derived peptide that stimulates the release of growth hormone and prolactin from rat anterior pituitary cells, Prog Neurocndocr Immunol 1990;3:258-265.
25. MacLeod RM, Hughes FM Jr, Gorospe WC, Spangelo BL: Synthesis, release and actions of intcrlcukin-6 in neuroendocrine tissues: Methods and overview, Methods Neurosci 1993:17: 3-15.
26. Blackshear PJ: Approaches to the study of protein kinase C involvement in signal transduction, Am J Med Sci 1988:296:231-240.
27. KJir JJ, McClellan JL, Kluger MJ: Intcrleukin-1 β causes the increase in anterior hypothalamic interlcukin-6 during LPS-induccd fever in rats, Am J Physiol 1994;266:R1845-R1848.
28. Banks WA, Kastin AJ: Measurement of transport of cytokines across the blood-brain barrier, Methods Ncurosci 1993; 16:67-77.
29. Oitzl MS, van Oers H.Schobitz B, de Kloet ER: Interleukin-Iβ, but not interlcukin-6, impairs spatial navigation learning, Brain Res 1993: 613:160-163.
30. Griffin WST, Sheng JG, Roberts GW, Mrak RE: Interleukin-1 expression in different plaque types in Alzheimer's disease: Significance in plaque evolution, J Ncuropathol Exp Neurol 1995;54:276-281.
31. Mrak R, Sheng JG, Griffin ST: Glial cytokines in Alzheimer's disease: Review and pathogenic implications, Hum Pathol 1995;26:816-823.